CDH1 and pancreatic neoplasm: Since loss of E-cadherin expression is a most robust marker of EMT, we conducted a large-scale RNAi screen of the druggable genome in mesenchymal PANC-1 pancreatic cancer cells to identify novel regulators of E-cadherin protein expression.